Supply Chain Intelligence

Tvardi Therapeutics, Inc. Supply Chain

TVRD supply chain intelligence for Tvardi Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

TVRD ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

7Suppliers
3Customers
2Debt Items
20Related Chains

Tvardi Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
VENDOR-A VENDOR-A 92% Vendor A accounted for 41% of operating expenses and 72% of accounts payable as of March 31, 2026
VENDOR-B VENDOR-B 92% Vendor B accounted for 7% of operating expenses and 10% of accounts payable as of March 31, 2026
BAYLOR-COLLEGE-OF-MEDICINE BAYLOR-COLLEGE-OF-MEDICINE 85% Under the BCM First Agreement, we obtained an exclusive, worldwide, sublicensable license under BCM's rights to certain patents in oncology and certain non-oncology indications (BCM Patent Rights), t…
NATIONAL-INSTITUTES-OF-HEALTH NATIONAL-INSTITUTES-OF-HEALTH 80% Under the BCM Second Agreement, we obtained an exclusive, worldwide, sublicensable license under certain patents and patent applications co-owned by BCM and the National Institutes of Health (NIH)
STEM-MED-LIMITED-PARTNERSHIP STEM-MED-LIMITED-PARTNERSHIP 80% StemMed assigned the BCM First Agreement to us in connection with the transfer of all or substantially all of the assets and businesses to which the BCM First Agreement relates
ORANY ORANY 72% ary representations and warranties by the parties, a grant to Patheon of certain limited license rights to Cara’s intellectual property in connection with Patheon’s performance of the services under …
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from TVRD graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from TVRD graph: ary representations and warrantie…

Tvardi Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
HUTCHMED-CHINA-LIMITED HUTCHMED-CHINA-LIMITED 90% development of multiple oncology programs including surufatinib (Sulanda) at HUTCHMED (China) Limited and ramucirumab (Cyramza) for HCC at Eli Lilly and Company
ORANY ORANY 72% of $50.0 million for the purchase of an aggregate of 244,963 shares of Cara common stock at a price of $204.11 per share, which represented a premium over a pre-determined average closing price of th…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from TVRD graph: of $50.0 million for the purchase of an aggregate of 244,963 shares of Cara common stock at a price of $204.11 per s…

Tvardi Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
TVRD-DEBT-13152 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
TVRD-DEBT Debt stack $174,000 90% Market cache reports total debt of $174,000.

Tvardi Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Tvardi Therapeutics, Inc..

Tvardi Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
TVRD-OWNER-DANSKE-BANK-A-S DANSKE BANK A/S 90% 13F overlay lists DANSKE BANK A/S as top holder; 1 tracked holders.

Tvardi Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DYN Dyne Therapeutics, Inc. 100.00 2
NVO Novo Nordisk A/S 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
AKTS Aktis Oncology, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
IMMP Immutep Limited 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
FHTX Foghorn Therapeutics Inc. 100.00 2
DEO Diageo plc 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
CCCC C4 Therapeutics, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
View TVRD supply chain intel →

Explore the full interactive supply chain map for Tvardi Therapeutics, Inc..

Open TVRD supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map